EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dehydrocostus Lactone Suppresses Hepatocellular Carcinoma by Inhibiting Protein Tyrosine Kinase‐7 Mediated β‐Catenin Signaling

Xiwen Fan iD, Junhui Li, Yu Qiao, Yuwen Zhong, Xuecheng Ge, Yaoshuai Zhang, Zishu Wang, Feng Qian, Weixin Ren

Phytotherapy Research · 2026-11 · 40 (11) · 6069-6093

DOI: 10.1002/ptr.70313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 05.06.2026. Verfasst von Xiwen Fan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, People's Republic of China. Hauptthemen laut MEDLINE: Lactones, Carcinoma, Hepatocellular, Liver Neoplasms, beta Catenin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dehydrocostus lactone (DHL), a sesquiterpene lactone isolated from Aucklandia lappa (Radix Aucklandiae), is a bioactive compound widely used in traditional medicine for its anti‐inflammatory and antitumor properties. However, its precise molecular target and pharmacological mechanisms in hepatocellular carcinoma (HCC) remain largely undefined. This study aimed to elucidate the role of protein tyrosine kinase 7 (PTK7) in HCC and to investigate the antitumor efficacy and mechanism of DHL as a PTK7‐targeting compound that inhibits the β‐catenin signaling pathway. The single‐cell transcriptomic data and spatial transcriptomic data, together with publicly available TCGA‐LIHC and GEO datasets, were integrated to determine PTK7 expression patterns and pathway associations in HCC. Cell proliferation, apoptosis, mitochondrial membrane potential, and invasion assays were performed to evaluate DHL activity. Molecular docking, cellular thermal shift assay (CETSA), drug affinity responsive target stability (DARTS) assays, and co‐immunoprecipitation assays were conducted to confirm that DHL directly inhibited interaction of PTK7 and β‐catenin. The in vivo antitumor efficacy of DHL was assessed in Hep3B and Huh7 xenograft models. PTK7 was highly expressed in malignant HCC cells and positively correlated with β‐catenin pathway activation. DHL treatment disrupted the PTK7–β‐catenin interaction, inhibited proliferation, induced mitochondrial‐dependent apoptosis, and reduced invasion by downregulating matrix metalloproteinase (MMP)‐2 and MMP‐9. DHL also decreased phosphorylation of protein kinase B (AKT), extracellular signal‐regulated kinase (ERK), and β‐catenin in a dose‐dependent manner. CETSA and DARTS assays confirmed the direct inhibition of PTK7 by DHL. In vivo, DHL markedly suppressed tumor growth, achieving inhibition rates of ~34%–54% in Hep3B and 28%–58% in Huh7 xenograft models. DHL exerts significant antitumor effects in HCC by directly targeting PTK7 and inhibiting β‐catenin signaling. These findings identify PTK7 as a potential therapeutic target and support the development of DHL as a promising natural agent for PTK7‐directed HCC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactonesCarcinoma, HepatocellularLiver Neoplasmsbeta CateninSesquiterpenesReceptor Protein-Tyrosine KinasesCell Adhesion MoleculesHumansAnimalsCell ProliferationCell Line, TumorApoptosisMiceMice, NudeSignal TransductionXenograft Model Antitumor AssaysMolecular Docking SimulationMice, Inbred BALB CMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

Aucklandia lappaPTK7Wnt/β‐catenin signalingdehydrocostus lactonehepatocellular carcinomatraditional medicine

Substanzen

Lactonesbeta CateninSesquiterpenesReceptor Protein-Tyrosine Kinasesdehydrocostus lactonePTK7 protein, humanCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Interventional Radiology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, People's Republic of China.
  • Department of Interventional Therapy, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China.
  • Shanghai Frontiers Science Center of Drug Target Identification and Delivery, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University, Bengbu, Anhui, People's Republic of China.
  • Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University, Bengbu, Anhui, People's Republic of China.

ORCID-Profile: Xiwen Fan

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Xinjiang Uygur Autonomous Region

Zitieren

APA

Fan, X., Li, J., Qiao, Y., Zhong, Y., Ge, X., Zhang, Y., Wang, Z., Qian, F., & Ren, W. (2026). Dehydrocostus Lactone Suppresses Hepatocellular Carcinoma by Inhibiting Protein Tyrosine Kinase‐7 Mediated β‐Catenin Signaling. Phytotherapy Research, 40(11), 6069-6093. https://doi.org/10.1002/ptr.70313

Vancouver

Fan X, Li J, Qiao Y, Zhong Y, Ge X, Zhang Y, et al. Dehydrocostus Lactone Suppresses Hepatocellular Carcinoma by Inhibiting Protein Tyrosine Kinase‐7 Mediated β‐Catenin Signaling. Phytotherapy Research. 2026;40(11):6069-6093. doi:10.1002/ptr.70313

BibTeX
@article{Fan2026,
  author = {Fan, Xiwen and Li, Junhui and Qiao, Yu and Zhong, Yuwen and Ge, Xuecheng and Zhang, Yaoshuai and Wang, Zishu and Qian, Feng and Ren, Weixin},
  title = {Dehydrocostus Lactone Suppresses Hepatocellular Carcinoma by Inhibiting Protein Tyrosine Kinase‐7 Mediated β‐Catenin Signaling},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {11},
  pages = {6069--6093},
  doi = {10.1002/ptr.70313}
}
Kostenlos starten →